Chinese Markets for Diabetes Drugs

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Jointown Pharmaceutical Group Co Ltd

Jointown Pharmaceutical Group Co Ltd

  • $ 55
  • Company report
  • by Wright Investors' Service
  • October 2014
  • 55 pages

A textual analysis of the financial results for Jointown Pharmaceutical Group Co Ltd compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Drug and Medication | Countries: China

Shanghai Fosun Pharmaceutical (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

Shanghai Fosun Pharmaceutical (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Shanghai Fosun Pharmaceutical SWOT Analysis report provides you a ...

Industries: Drug and Medication | Countries: China

Mylan Laboratories Limited - Strategic SWOT Analysis Review

Mylan Laboratories Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

Summary Mylan Laboratories Limited (Mylan Laboratories) is a pharmaceutical company. The company's product segments include manufacturing and supply of active pharmaceutical ingredients (APIs). The company offers its products in various therapeutic categories, including central nervous system (CNS) agents, ...

Industries: Drug and Medication | Countries: United States, India, World, Australia, South Africa, China

Beijing Zizhu Pharmaceutical Co., Ltd SWOT Analysis, Strategy, Revenues and Profits

Beijing Zizhu Pharmaceutical Co., Ltd SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Drug and Medication | Countries: China

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (Symbol:002219) SWOT Analysis, Strategy, Revenues and Profits

Gansu Duyiwei Biological Pharmaceutical Co., Ltd. (Symbol:002219) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Gansu Duyiwei Biological Pharmaceutical Co., Ltd. SWOT Analysis report ...

Industries: Drug and Medication | Countries: China

Ginwa Enterprise (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

Ginwa Enterprise (Symbol:Group) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ginwa Enterprise SWOT Analysis report provides you a strategic analysis ...

Industries: Drug and Medication | Countries: China

SCI Pharmtech, Inc. (Symbol:4119) SWOT Analysis, Strategy, Revenues and Profits

SCI Pharmtech, Inc. (Symbol:4119) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SCI Pharmtech, Inc. SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: Taiwan, China

Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review

Yabao Pharmaceutical Group Co., Ltd. (600351) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

Summary Yabao Pharmaceutical Group Co., Ltd. (Yabao Pharmaceutical) is a pharmaceutical company. The company manufactures and markets pharmaceuticals products including western and Chinese medicines, APIs, and health care products. Its products include sennae leaf, senna pods, clove, rhubarb, compound ...

Industries: Drug and Medication | Countries: China

Zhejiang Jingxin Pharmaceutical Co., Ltd (Symbol:002020) SWOT Analysis, Strategy, Revenues and Profits

Zhejiang Jingxin Pharmaceutical Co., Ltd (Symbol:002020) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Zhejiang Jingxin Pharmaceutical Co., Ltd SWOT Analysis report provides ...

Industries: Drug and Medication | Countries: China

China Medicine Corporation (Symbol:CHME) SWOT Analysis, Strategy, Revenues and Profits

China Medicine Corporation (Symbol:CHME) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. China Medicine Corporation SWOT Analysis report provides you a strategic ...

Industries: Drug and Medication | Countries: China

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 618 4302

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.